Healthtech Startups

Bain Capital Life Sciences is an investment firm that deploys capital into biopharmaceutical, medical device, diagnostic, and life science tool companies globally, focusing on enterprises addressing unmet medical needs. The team combines venture, private equity, and operating expertise to support clinical and commercial-stage companies through key phases of development and value creation.

3 investors

Bairitone develops a wearable patch-based system that maps airway vibrations to detect sleep apnea obstruction causes without MRI, X-ray, or ultrasound. The platform provides dynamic airway mapping and precision therapy guidance for sleep health providers and patients.

3 investors

Banjo Health builds AI-driven software to automate and streamline the prior authorization process for health plans and pharmacy benefit managers (PBMs). Its technology embeds intelligence into payer decision-making workflows to reduce administrative burden and speed access to care for providers and patients.

3 investors

Banquet Health provides software for hospital foodservice teams to manage clinical nutrition operations. The platform helps dietitians and kitchen staff reduce food-related harm, improve patient satisfaction, and streamline communication around meal preparation and delivery.

3 investors

Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease. The company focuses on stroke and cardiovascular applications.

3 investors

Oli is a wireless, wearable monitoring device designed for maternal and fetal health during labor and delivery that predicts complications like postpartum hemorrhage before they become emergencies. The device serves obstetric care teams and aims to enable earlier clinical intervention through real-time monitoring and predictive intelligence.

3 investors

Beam Benefits is a digitally-native employee benefits company offering dental, vision, life, and supplemental health insurance through an online platform with personalized rewards and AI-powered underwriting. The company serves employers and their employees across 45 states in the United States.

3 investors

Beep is a fully digital home healthcare service that provides laboratory tests (5,000+ types), vaccines, and infusions at the patient's home, booked via its app or website. It serves individuals paying privately or through more than 40 accepted health insurance plans, operating in Rio de Janeiro, São Paulo, and Brasília, Brazil.

3 investors

BehaVR develops VR-based (XR) therapeutics for mental and behavioral health, translating clinical science into immersive programs that address stress, anxiety, fear, pain management, addiction recovery, and maternal health. Its solutions incorporate education, mindfulness, and meta-cognition to help patients build coping skills in a safe environment.

3 investors

BEKhealth builds an AI-powered platform that reads structured and unstructured EHR data to support clinical trial feasibility, patient matching, and real-world data generation. It serves sponsors, CROs, site networks, and research sites in the clinical research and life sciences industry.

3 investors

BestDoc provides a suite of patient relationship management and omni-channel engagement products for hospitals to streamline operations from scheduling through discharge. The company serves hospitals across India and the Middle East, having reached over 4 million patients across more than 250 facilities.

3 investors

Betterleap offers an AI recruiting agent for healthcare organizations that searches a database of 35M+ verified healthcare professionals, confirms state licensing data, and builds candidate pipelines with automated personalized outreach. It also provides ATS integrations, talent rediscovery, and an insights dashboard for talent acquisition teams.

3 investors

BetterMynd is a teletherapy service providing online mental health counseling to college students through partnerships with campuses. It serves higher education institutions in the United States, connecting students with mental health providers.

3 investors

BigOmics develops interactive platforms for life scientists to analyze omics data, enabling researchers to process and visualize experimental results in minutes rather than weeks. The company serves academic laboratories and enterprise life science organizations seeking to accelerate discovery through data-driven precision medicine.

3 investors

3 investors

Biocollabs offers the Alcohol Belly Protocol, a plant-based liquid supplement designed to support liver function and reduce visceral fat accumulation in people who consume alcohol. The product targets metabolic health and weight loss through improved liver enzyme activity and fat metabolism.

3 investors

Biodock provides an AI image analysis platform designed for researchers and scientists to train, run, and interpret deep learning models on biological images without requiring coding expertise. The platform enables rapid model creation, distributed execution at scale, and detailed quantitative analysis for research organizations in biotech and life sciences.

3 investors

Biofidelity develops decentralized biomarker testing solutions, starting with Aspyre Lung Reagents for analyzing DNA and RNA variants in lung cancer research. The company enables genomic testing on existing qPCR platforms globally, avoiding the cost and complexity of next-generation sequencing.

3 investors

Biohaven is a pharmaceutical company that discovers, develops, and commercializes medications for neurological and neuropsychiatric diseases, including epilepsy, pain, mood disorders, OCD, spinocerebellar ataxia, and spinal muscular atrophy. The company operates as a modern publicly traded entity and was acquired by Pfizer in May 2022 for approximately $13 billion.

3 investors

BioHive develops skin organoid technology derived from iPSCs, offering customizable organoids with multiple cell types for toxicity, efficacy, and inflammatory analysis. It serves the pharmaceutical and dermo-cosmetic industries to reduce R&D costs and reliance on animal models.

3 investors

BiologicsMD is a preclinical therapeutic company developing patent-protected recombinant fusion proteins that target the parathyroid hormone receptor for treatments in hair loss, bone disorders, and oncology. Its proteins combine an active stimulatory domain with a binding domain to localize therapy at the disease site for targeted, infrequent dosing.

3 investors

Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.

3 investors

BioBrace develops a reinforced bioinductive implant combining collagen scaffolds with PLLA microfilaments to support soft tissue repair, particularly for tendon healing procedures. The product serves orthopedic surgeons and is designed for open or arthroscopic surgical applications.

3 investors

Biosapien develops treatments for cancer that are delivered locally to shrink tumors, relieve symptoms, and reduce the need for surgeries.

3 investors